-
15081por Sheth, Kaushal, Boddula, Dr Raman, Kapoor, Dr Dharmesh, Reddy, Dr Manojkumar R, Reddy, Dr Ashish“…Factors for which association with NODAT could not be found were: Age, Hepatitis C cirrhosis, alcoholic cirrhosis, pre-transplant BMI, baseline MELD score, pre-transplant FBS, donor age, donor gender, donor BMI, donor FBS & Hba1c, donor CT LAI (Liver Attenuation Index, L-S) value, Steroid dose at discharge, immediate post-op trough Tacrolimus level and use of Everolimus. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15082por Tookes, Hansel E., Oxner, Asa, Serota, David P., Alonso, Elizabeth, Metsch, Lisa R., Feaster, Daniel J., Ucha, Jessica, Suarez, Edward, Forrest, David W., McCollister, Kathryn, Rodriguez, Allan, Kolber, Michael A., Chueng, Teresa A., Zayas, Sheryl, McCoy, Bernice, Sutherland, Kyle, Archer, Chetwyn, Bartholomew, Tyler S.“…Adapting a low threshold, comprehensive treatment model for PWID with HIV can leverage syringe services programs (SSPs) to increase availability and accessibility of antiretrovirals (ART), medications for opioid use disorder (MOUD), and hepatitis C cure. We developed Tele-Harm Reduction, a telehealth-enhanced, harm reduction intervention delivered within an SSP venue. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15083Publicado 2006Tabla de Contenidos: “…Caliendo and Charles E. Hill -- Hepatitis C / D. Robert Dufour --…”
Table of contents
Publisher description
Software Libro -
15084por Forero-Peña, David A., Carrión-Nessi, Fhabián S., Lopez-Perez, Mary, Sandoval-de Mora, Marisol, Amaya, Iván D., Gamardo, Ángel F., Chavero, Melynar, Figuera, Luisamy, Marcano, María V., Camejo-Ávila, Natasha A., Hidalgo, Mariana, Arenas, Cariagne J., Arévalo-Herrera, Myriam, Herrera, Sócrates“…Clinical evaluation and laboratory tests for dengue virus (DENV), chikungunya virus (CHIKV), viral hepatitis [hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV)], and leptospirosis (LEP) were performed by enzyme-linked immunosorbent assays. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15085“…METHOD: Annual incident cases, deaths, age-standardized incidence rates (ASIRs), and age-standardized mortality rates (ASMRs) of primary liver cancer and its etiologies, including hepatitis B, hepatitis C, alcohol use, nonalcoholic steatohepatitis, and other causes, between 1990 and 2019 were collected from GBD study 2019. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15086por Calvo, Fran, Guillén, Ana, Carbonell, Xavier, Alfranca, Rebeca, Beranuy, Marta, Parés-Bayerri, Alícia, Font-Mayolas, Sílvia“….-243), and alcohol (b =-0.199)], cardiovascular diseases (b = − 0.223), tuberculosis (b = − 0.163), high blood pressure (b =-0.203), criminal record (b =-0.167), and hepatitis C (b =-0.129). When we separated the causes of death for Spanish-born and foreign-born subjects, we found that the main predictors of death among Spanish-born IEHs were opiate use disorder (b =-0.675), COPD (b =-0.479), cocaine use disorder (b =-0.208), high blood pressure (b =-0.358), multiple drug use disorder (b =-0.365), cardiovascular disease (b =-0.306), dual pathology (b =-0.286), female gender (b =-0.181), personality disorder (b =-0.201), obesity (b =-0.123), tuberculosis (b =-0.120) and having a criminal record (b =-0.153). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15087por Cantudo-Cuenca, Maria Rosa, Jiménez-Galán, Rocio, Almeida-González, Carmen V., Morillo-Verdugo, Ramón“…The variables analyzed in the study were demographics (sex and age), HIV transmission mode, and the following variables at the time of comedication collection: hepatitis C virus or hepatitis B virus coinfection, HIV plasma viral load (copies/mL) and CD4+ T-cell count (cells/µL), Centers for Disease Control and Prevention HIV classification, number of hospital admissions and emergency room visits, and antiretroviral therapy-related features (type at baseline, treatment-naïve status, and number of changes since starting antiretroviral therapy). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15088por Luo, Tong, Lin, Zhaosen, Wu, Zhenxian, Cen, Ping, Nong, Aidan, Huang, Rongye, Che, Jianhua, Liang, Fengfeng, Yang, Yuan, Liu, Jie, Huang, Li, Cai, Jie, Ou, Yanyun, Ye, Li, Bao, Lijuan, Liang, Bingyu, Liang, Hao“…BACKGROUND: Data on recent human immunodeficiency virus (HIV), hepatitis C virus (HCV) and syphilis prevalence among drug users in the Southwest China are sparse despite the high burden of drug use. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15089por Cento, Valeria, Mirabelli, Carmen, Salpini, Romina, Dimonte, Salvatore, Artese, Anna, Costa, Giosuè, Mercurio, Fabio, Svicher, Valentina, Parrotta, Lucia, Bertoli, Ada, Ciotti, Marco, Di Paolo, Daniele, Sarrecchia, Cesare, Andreoni, Massimo, Alcaro, Stefano, Angelico, Mario, Perno, Carlo Federico, Ceccherini-Silberstein, Francesca“…BACKGROUND: Because of the extreme genetic variability of hepatitis C virus (HCV), we analyzed whether specific HCV-genotypes are differently prone to develop resistance to linear and macrocyclic protease-inhibitors (PIs). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15090por Boggild, Andrea K, Geduld, Jennifer, Libman, Michael, Ward, Brian J, McCarthy, Anne E, Doyle, Patrick W, Ghesquiere, Wayne, Vincelette, Jean, Kuhn, Susan, Freedman, David O, Kain, Kevin C“…Among the 828 immigrants with definitive travel-related diagnoses, the most frequent etiologies were latent tuberculosis (n = 229 [27.7%]), chronic hepatitis B (n = 182 [22.0%]), active tuberculosis (n = 97 [11.7%]), chronic hepatitis C (n = 89 [10.7%]), and strongyloidiasis (n = 41 [5.0%]). …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15091por Mocroft, Amanda, Lundgren, Jens D., Ross, Michael, Law, Matthew, Reiss, Peter, Kirk, Ole, Smith, Colette, Wentworth, Deborah, Neuhaus, Jacqueline, Fux, Christoph A., Moranne, Olivier, Morlat, Phillipe, Johnson, Margaret A., Ryom, Lene“…Older age, intravenous drug use, hepatitis C coinfection, lower baseline eGFR, female gender, lower CD4 count nadir, hypertension, diabetes, and cardiovascular disease (CVD) predicted CKD. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15092por Schütz, Ekkehard, Fischer, Anna, Beck, Julia, Harden, Markus, Koch, Martina, Wuensch, Tilo, Stockmann, Martin, Nashan, Björn, Kollmar, Otto, Matthaei, Johannes, Kanzow, Philipp, Walson, Philip D., Brockmöller, Jürgen, Oellerich, Michael“…Only slightly higher values (median 5.9%, 95% CI 4.4%–10.3%) were found in 68 samples from 17 hepatitis C virus (HCV)–positive, rejection-free patients. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15093por Nance, Robin, Vannappagari, Vani, Smith, Kimberly, Johannes, Catherine, Calingaert, Brian, Saltus, Catherine, Boswell, Stephen, Rodriguez, Benigno, Moore, Richard, Eron, Joseph, Geng, Elvin, Mathews, W Christopher, Saag, Michael S, Kitahata, Mari, Delaney, JaC, Crane, Heidi M“…We used Cox models adjusting for age, sex, race/ethnicity, hepatitis B, hepatitis C, tuberculosis, HIV risk factor, CD4 count, days since last HIV viral load, and site. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15094por Degenhardt, Louisa, Peacock, Amy, Colledge, Samantha, Leung, Janni, Grebely, Jason, Vickerman, Peter, Stone, Jack, Cunningham, Evan B, Trickey, Adam, Dumchev, Kostyantyn, Lynskey, Michael, Griffiths, Paul, Mattick, Richard P, Hickman, Matthew, Larney, Sarah“…We did a global multistage systematic review to identify the prevalence of IDU among people aged 15–64 years; sociodemographic characteristics of and risk factors for people who inject drugs (PWID); and the prevalence of HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV) among PWID. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15095por Solomon, Sunil S., McFall, Allison M., Lucas, Gregory M., Srikrishnan, Aylur K., Kumar, Muniratnam S., Anand, Santhanam, Quinn, Thomas C., Celentano, David D., Mehta, Shruti H.“…BACKGROUND: A major barrier to achieving ambitious targets for global control of HIV and hepatitis C virus (HCV) is low levels of awareness of infection among key populations such as men who have sex with men (MSM) and people who inject drugs (PWID). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15096por Maegawa, Felipe B., Shehorn, Lauren, Aziz, Hassan, Kettelle, John, Jie, Tun, Riall, Taylor S.“…A total of 361 patients (76.0%) were men, 294 (61.9%) were white; 308 (64.8%) were hepatitis C positive, and 346 (72.8%) were categorized as CTP class A. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15097“…She also had a history of hepatitis C treated with interferon-ribavirin at age 52, with clearance of virus. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15098por Monrose, Erica, Zamudio, Andres Ramirez, Aristide, Alaina, Navalurkar, Reema, Bedekar, Rashi, Ferrara, Lauren, Kushner, Tatyana“…ICP and control patients were similar for: median age (OR 1.02, 95% CI.99-1.06), nulliparity (OR.79, 95% CI.48-1.30) and prevalence of hepatitis C (OR 1.35, 95% CI.08-21.67). In regards to metabolic risk factors, ICP patients and control patients were similar in prevalence of obesity (body mass index>30kg/m^2; OR 1.01, 95% CI.62-1.61), hemoglobin A1c>5.5% (OR.80, 95% CI.34-1.9), total cholesterol >200 mg/dL (OR 4.15, 95% CI.83-20.84), and prevalence of hypertension (OR.69, 95% CI.31-1.52). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15099por Marks, Charles, Borquez, Annick, Jain, Sonia, Sun, Xiaoying, Strathdee, Steffanie A., Garfein, Richard S., Milloy, M-J, DeBeck, Kora, Cepeda, Javier A., Werb, Dan, Martin, Natasha K.“…CONCLUSIONS: In addition to its known benefits on preventing HIV, hepatitis C virus (HCV), and overdose among PWID, our modeling suggests that OAT scale-up may also reduce the number of IDU initiations and PWID population size.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
15100por Kumar, Gayathri S., Pezzi, Clelia, Wien, Simone, Mamo, Blain, Scott, Kevin, Payton, Colleen, Urban, Kailey, Hughes, Stephen, Kennedy, Lori, Cabanting, Nuny, Montour, Jessica, Titus, Melissa, Aguirre, Jenny, Kawasaki, Breanna, Ford, Rebecca, Jentes, Emily S.“…Data were collected for communicable diseases commonly screened for during the exam, including tuberculosis (TB), hepatitis B, hepatitis C, malaria, strongyloidiasis, schistosomiasis, other intestinal parasites, syphilis, gonorrhea, chlamydia, and human immunodeficiency virus, as well as elevated blood lead levels (EBLL). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto